Cost-effectiveness of cefonicid sodium versus cefoxitin sodium for the prevention of postoperative infections after nonelective cesarean section.
D000328:Adult; D001424:Bacterial Infections / Q000191:economics / Q000517:prevention & control*; D002435:Cefamandole / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015790:Cefonicid; D002440:Cefoxitin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002585:Cesarean Section; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D011183:Postoperative Complications / Q000191:economics / Q000517:prevention & control*; D011247:Pregnancy
D002435:Cefamandole; D015790:Cefonicid; D002440:Cefoxitin